metformin has been researched along with exendin (9-39) in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, X; Drucker, DJ; Lamont, BJ; Maida, A | 1 |
| Cho, YM; Kieffer, TJ | 1 |
2 other study(ies) available for metformin and exendin (9-39)
| Article | Year |
|---|---|
Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-α in mice.
Topics: Animals; Cell Line; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Eating; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Hypoglycemic Agents; Male; Metformin; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Peptide Fragments; PPAR alpha; Receptors, Gastrointestinal Hormone; Receptors, Glucagon; Signal Transduction | 2011 |
New aspects of an old drug: metformin as a glucagon-like peptide 1 (GLP-1) enhancer and sensitiser.
Topics: Animals; Cell Line; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Eating; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Male; Metformin; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Models, Biological; Peptide Fragments; PPAR alpha; Receptors, Gastrointestinal Hormone; Receptors, Glucagon; Signal Transduction | 2011 |